Levetiracetam
Brand name: Levetiracetam
Rank #165 of 500 drugs by total cost
$96.1M
Total Cost
1,723,736
Total Claims
$96.1M
Total Cost
35,923
Prescribers
$56
Cost per Claim
222,423
Beneficiaries
2,613,320
30-Day Fills
$2,676
Avg Cost/Provider
48
Avg Claims/Provider
About Levetiracetam
Levetiracetam (sold as Levetiracetam) was prescribed 1,723,736 times by 35,923 Medicare Part D providers in 2023, costing the program $96.1M. At $56 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 162 | Dexlansoprazole (Dexlansoprazole Dr) | $98.7M | 275,116 |
| 163 | Interferon Beta-1a (Avonex) | $98.3M | 11,314 |
| 164 | Guselkumab (Tremfya) | $97.1M | 7,102 |
| 165 | Levetiracetam (Levetiracetam) | $96.1M | 1,723,736 |
| 166 | Oxycodone Myristate (Xtampza Er) | $96.1M | 141,266 |
| 167 | Sevelamer Carbonate (Sevelamer Carbonate) | $95.6M | 277,192 |
| 168 | Aripiprazole Lauroxil (Aristada) | $93.3M | 31,120 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology